Scientific Sessions 2025  /  Rewriting the Code for Cardiac Amyloid: Novel Identification, Treatment, and Cure  /  Commentary: Screening for Cardiac Amyloid
Logo

American Heart Association

  78
  0

Final ID:

Commentary: Screening for Cardiac Amyloid

  • Ahmad, Faraz  ( University of Pennsylvania , Philadelphia , Pennsylvania , United States )
    • Author Disclosures:
    Faraz Ahmad: DO have relevant financial relationships ; Research Funding (PI or named investigator):Pfizer:Past (completed) ; Consultant:AstraZeneca:Past (completed) ; Speaker:AstraZeneca:Past (completed) ; Speaker:Alnylam:Past (completed) ; Consultant:Alnylam Pharmceuticals:Active (exists now) ; Research Funding (PI or named investigator):Abiomed/Johnson and Johnson:Active (exists now) ; Research Funding (PI or named investigator):AstraZeneca:Active (exists now) ; Research Funding (PI or named investigator):Atman Health:Past (completed) ; Research Funding (PI or named investigator):Tempus:Active (exists now) ; Research Funding (PI or named investigator):Atman Health :Past (completed)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Rewriting the Code for Cardiac Amyloid: Novel Identification, Treatment, and Cure

Monday, 11/10/2025 , 01:30PM - 02:45PM

Featured Science

More abstracts on this topic:
Commentary: Mab Therapy for Cardiac Amyloid

Alexander Kevin, Witteles Ronald

Commentary: Gene Therapy for Cardiac Amyloid

Grogan Martha, Grodin Justin, Ambardekar Amrut

More abstracts from these authors:
Processing EHR data to build machine learning tools

Nadkarni Girish, Ahmad Faraz

Bridging Research and Health Systems for Smarter Implementation

Ahmad Faraz

You have to be authorized to contact abstract author. Please, Login
Not Available